Abstract
Purpose
Whole brain radiotherapy (WBRT) is a treatment strategy used commonly to relieve burdensome symptoms and improve quality of life (QOL) in patients with multiple brain metastases. The purpose of this study is to determine changes in fatigue score following WBRT as it is a common symptom experienced in this population.
Methods
Fatigue and overall QOL scores were collected prospectively in patients for up to 3 months post-WBRT by several questionnaires at different times including the following: Edmonton Symptom Assessment System (ESAS), Brain Symptom and Impact Questionnaire (BASIQ), Spitzer Questionnaire, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), EORTC brain module (EORTC QLQ-BN20 + 2), EORTC QLQ-C15-PAL, and Functional Assessment of Cancer Therapy—General (FACT-G). Questionnaires were grouped for analysis by Wilcoxon Signed Rank test according to the scale of ranking into 0–10, 1–4, and 0–4.
Results
Thirty-six patients were interviewed with the ESAS or BASIQ. The median age was 65 years old, and median Karnofsky Performance Status (KPS) was 70. There was a significant increase in fatigue score from baseline to month 1 (p = 0.02), and months 2 and 3 had no significant change. There was a significant correlation between fatigue and overall QOL score at baseline and month 1 (p = 0.01, p < 0.0001), respectively. Two hundred and twenty-eight patients were surveyed with Spitzer, C15-PAL, BN20 + 2, QLQ-C30, or FACT-G. Median age was 64 years old and median KPS was 80. Compared to baseline, fatigue score was significantly higher at month 1 (p < 0.0001) and month 2 (p = 0.001), with no significant change at month 3. Significant correlation was found between fatigue and overall QOL at baseline, months 1, 2 (p < 0.0001), and 3 (p = 0.0009). For all groups, there was no significant change in fatigue score between patients with or without dexamethasone (Dx), except for the fatigue changed score of the group with scale 0–4.
Conclusions
Fatigue was significantly increased from baseline to month 1 in all patients, and most patients experienced no difference in fatigue if they were receiving Dx. Increased fatigue was significantly related with decreased overall QOL.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wong J, Hird A, Kirou-Mauro A, Napolskikh J, Chow E (2008) Quality of life in brain metastases radiation trials: a literature review. Curr Oncol 15(5):25–45
Thomas SS, Dunbar EM (2010) Modern multidisciplinary management of brain metastases. Curr Oncol Rep 12(1):34–40
Caissie A, Nguyen J, Chen E, Zhang L, Sahgal A, Clemons M et al (2012) Quality of life in patients with brain metastases using the EORTC QLQ-BN20 + 2 and QLQ-C15-PAL. Int J Radiat Oncol Biol Phys 83(4):1238–1245
Khan L, Cramarossa G, Lemke M, Nguyen J, Zhang L, Chen E et al (2013) Symptom clusters using the Spitzer quality of life index in patients with brain metastases—a reanalysis comparing different statistical methods. Support Care Cancer 21(2):467–473
Hird A, Wong J, Zhang L, Tsao M, Barnes E, Danjoux C et al (2010) Exploration of symptoms clusters within cancer patients with brain metastases using the Spitzer Quality of Life Index. Support Care Cancer 18(3):335–342
Chow E, Fan G, Hadi S, Wong J, Kirou-Mauro A, Filipczak L (2008) Symptom clusters in cancer patients with brain metastases. Clin Oncol (R Coll Radiol) 20(1):76–82
Cramarossa G, Chow E, Zhang L, Bedard G, Zeng L, Sahgal A et al (2013) Predictive factors for overall quality of life in patients with advanced cancer. Support Care Cancer 21(6):1709–1716
Chow E, Davis L, Holden L, Tsao M, Danjoux C (2005) Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manag 30(1):18–23
Wong J, Hird A, Zhang L, Tsao M, Sinclair E, Barnes E et al (2009) Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy. Int J Radiat Oncol Biol Phys 75(4):1125–1131
Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD (2005) Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients’ perspective regarding complications. Am J Clin Oncol 28(2):173–179
Lien K, Zeng L, Zhang L, Nguyen J, Di Giovanni J, Popovic M et al (2012) Predictive factors for well-being in advanced cancer patients referred for palliative radiotherapy. Clin Oncol (R Coll Radiol) 24(6):443–451
Vardy J, Chiew KS, Galica J, Pond GR, Tannock IF (2006) Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer 94(7):1011–1015
Nguyen J, Caissie A, Zhang L, Zeng L, Dennis K, Holden L et al (2012) Dexamethasone toxicity and quality of life in patients with brain metastases following palliative whole-brain radiotherapy. J Radiat Oncol. doi:10.1007/s13566-012-0019-x
Bezjak A, Adam J, Panzarella T, Levin W, Barton R, Kirkbride P et al (2001) Radiotherapy for brain metastases: defining palliative response. Radiother Oncol 61(1):71–76
Tsao M, Xu W, Sahgal A (2012) A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 118(9):2486–2493
Acknowledgments
We thank the generous support of Bratty Family Fund, Michael and Karyn Goldstein Cancer Research Fund, Joseph and Silvana Melara Cancer Research Fund, and Ofelia Cancer Research Fund.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pulenzas, N., Khan, L., Tsao, M. et al. Fatigue scores in patients with brain metastases receiving whole brain radiotherapy. Support Care Cancer 22, 1757–1763 (2014). https://doi.org/10.1007/s00520-014-2140-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-014-2140-4